As for its clinical application for lung cancer diagnosis and treatment, MMP19 has been reported to promote the metastasis of lung cancer and is associated with increased mortality of lung cancer as an active biomarker (Yu et al., 2014). This evidence concerns the gene MMP19 and lung cancer.